BioLineRx Q3 2025 Earnings Preview: EPS Estimate at -$0.54, Revenue Estimate at $0.67M

BioLineRx (BLRX) is set to announce Q3 2025 earnings on Nov 24th. The consensus EPS estimate is -$0.54 (-Infinity% Y/Y), and the revenue estimate is $0.67M (-86.4% Y/Y). Historically, BLRX has beaten EPS estimates 38% of the time and revenue estimates 38% of the time over the last 2 years. There has been 1 upward revision in EPS estimates over the last 3 months.